[ad_1]
As long as the disease is detected early and treated, prostate cancer survivors can live longer than the average man without the disease.
Statistics suggest that a diagnosis of the disease can serve as a wake-up call to make patients more likely to monitor their health and improve their lifestyle. Figures provided by the Office for National Statistics estimate how survival to a variety of cancers varies depending on when they were diagnosed.
Men had a five-year survival rate 0.05% higher than the same age in the general population when prostate cancer was diagnosed early in the first phase; cases diagnosed at stages 1 and 2 now achieve a 5-year survival rate of 100%. When diagnosed at stage 3, the five-year survival rate is 96.5%, with a survival rate of 47.7% for people diagnosed later; The overall survival rate at all stages has increased from 80.2% in 2006 to 87.1% currently.
Updated statistics on cancer survivorship in the United Kingdom highlight the importance of catching prostate cancer at an early stage, but nearly 40% of cases are detected at an advanced stage, when the chances of survival at 5 -10 years are significantly reduced, says Karen Stalbow of Prostate Cancer UK.
These findings follow a series of breakthroughs in the treatment of advanced prostate cancer and efforts to diagnose the disease earlier. The chances of survival for men diagnosed with localized prostate cancer appear to be even higher than that of men without diagnosis, indicating that the diagnosis can improve personal health care and lead a healthier life.
Prostate cancer can be aggressive, some may not cause symptoms, and some men may even survive without form-based treatment, but it is impossible to distinguish between the two types using current blood tests for specific antigens of the prostate. Prostate cancer is the most common cancer in men. One in eight diagnoses will be diagnosed in their lifetime, 84% will live more than 10 years after diagnosis, which occurs on average between 65 and 69 years of age.
The overall figures give a mixed picture of several cancers for the 5-year survival rates: bad cancer went from 85.6% to 85.3%; bowel cancer dropped from 59.2% to 58%; the survival rate for melanoma is 93.9% for women and 89.2% for men; and pancreatic cancers are 6.4% for men and 7.5% for women.
Source link
